Literature DB >> 2552328

Lack of effect of opioid peptides, morphine and naloxone on superoxide formation in human neutrophils and HL-60 leukemic cells.

R Seifert1, R Burde, G Schultz.   

Abstract

There are controversial reports in the literature concerning the effects of opioids on superoxide (O2-) formation in phagocytes, these agents being either inhibitory or stimulatory. We re-examined this issue and compared the effects of the chemotactic peptide, N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMet-Leu-Phe), phorbol myristate acetate (PMA), ATP, platelet activating factor (PAF), cytochalasin B (CB) and prostaglandin E1 (PGE1) with those of various opioids on O2- formation in human neutrophils and HL-60 leukemic cells under defined experimental conditions. In the presence of CB, fMet-Leu-Phe and PAF concentration-dependently activated O2- formation in neutrophils with EC50 values of 20 nM and 100 nM, respectively. In the absence of CB, fMet-Leu-Phe and PAF were much less effective. PAF synergistically enhanced O2- formation induced by fMet-Leu-Phe. ATP at a concentration of 100 microM and the opioids, methionine enkephalin, beta-endorphin, dynorphin, [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin, [D-Ala2-D-Leu5]-enkephalin and morphine at concentrations between 10 pM to 1 microM did not activate O2- formation. ATP but not beta-endorphin potentiated fMet-Leu-Phe-induced O2- formation. O2- formation induced by a maximally stimulatory concentration of PMA (100 ng/ml) was enhanced by fMet-Leu-Phe but was unaffected by methionine enkephalin or PGE1. PMA at a non-stimulatory concentration (2 ng/ml) potentiated the effect of fMet-Leu-Phe but did not induce responsiveness to PAF, ATP or beta-endorphin. PGE1 strongly inhibited fMet-Leu-Phe-induced O2- formation, whereas morphine, methionine enkephalin and the opioid antagonist, naloxone, were without effect.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552328     DOI: 10.1007/BF00169214

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  4 in total

1.  Independent regulation of human neutrophil chemotactic receptors after activation.

Authors:  J G Bender; D E Van Epps; D E Chenoweth
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

2.  Bidirectional effect of met-enkephalin on macrophage effector functions.

Authors:  G Fóris; G A Medgyesi; M Hauck
Journal:  Mol Cell Biochem       Date:  1986-02       Impact factor: 3.396

3.  Receptor-cytoskeleton interactions and membrane traffic may regulate chemoattractant-induced superoxide production in human granulocytes.

Authors:  A J Jesaitis; J O Tolley; R A Allen
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

4.  Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera.

Authors:  Y Hashimoto; M Ziff; E R Hurd
Journal:  Arthritis Rheum       Date:  1982-12
  4 in total
  9 in total

1.  Lipopeptides are effective stimulators of tyrosine phosphorylation in human myeloid cells.

Authors:  S Offermanns; R Seifert; J W Metzger; G Jung; A Lieberknecht; U Schmidt; G Schultz
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Differential inhibition and potentiation of chemoattractant-induced superoxide formation in human neutrophils by the cell-permeant analogue of cyclic GMP, N2,2'-O-dibutyryl guanosine 3':5'-cyclic monophosphate.

Authors:  J Ervens; G Schultz; R Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-04       Impact factor: 3.000

3.  Differential inhibition and potentiation by cell-permeant analogues of cyclic AMP and cyclic GMP and NO-containing compounds of exocytosis in human neutrophils.

Authors:  K Wenzel-Seifert; J Ervens; R Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

4.  Naunyn-Schmiedeberg's Archives of Pharmacology under new editorship: change and continuity.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-24       Impact factor: 3.000

5.  Characterization of histamine H2-receptors in human neutrophils with a series of guanidine analogues of impromidine. Are cell type-specific H2-receptors involved in the regulation of NADPH oxidase?

Authors:  R Burde; A Buschauer; R Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

6.  Thapsigargin activates univalent- and bivalent-cation entry in human neutrophils by a SK&F I3 96365- and Gd3+-sensitive pathway and is a partial secretagogue: involvement of pertussis-toxin-sensitive G-proteins and protein phosphatases 1/2A and 2B in the signal-transduction pathway.

Authors:  K Wenzel-Seifert; D Krautwurst; I Musgrave; R Seifert
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

7.  Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides.

Authors:  R Seifert; G Schultz; M Richter-Freund; J Metzger; K H Wiesmüller; G Jung; W G Bessler; S Hauschildt
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

8.  Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors.

Authors:  R Burde; R Seifert; A Buschauer; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

9.  Partial inhibition of human neutrophil activation by FK-506 at supratherapeutic concentrations.

Authors:  K Wenzel-Seifert; R Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.